“INVESTIGATING NEURON-SPECIFIC ENOLASE AS A DIAGNOSTIC MARKER FOR EARLY DETECTION OF DIABETIC PERIPHERAL NEUROPATHY IN PATIENTS WITH TYPE II DIABETES MELLITUS”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 31, no. 9, Sept. 2024, pp. 1095-0, https://doi.org/10.53555/jb11kw29.